High-risk clonal haematopoiesis or future myeloid neoplasia

Disease

1 paper1 finding

  • Humans1

Associations

1

PRISM

upin humans1

1 study
  1. PRISM predicts high-risk clonal haematopoiesis or future myeloid neoplasia in humans (AUC 0.89 (95% CI 0.85–0.93)).

    “Validation of PRISM revealed an area under the curve of 0.89 (95% CI 0.85-0.93) in the UK Biobank test cohort”

    HumansUK Biobank internal test cohortn = 92,316

    Blood counts help flag high-risk blood cancer precursors

    EClinicalMedicine22 Sep 2026

More on PRISM

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 01 in 12 months
EClinicalMedicine

Blood counts help flag high-risk blood cancer precursors

The model categorised all high-risk cases as positive and pre-classified 40% of low-risk cases and 55% of negative cases as negative.The model categorised all high-risk cases as positive and pre-classified 40% of low-risk cases and 55% of negative cases as negative.

Cohort study of 461,576 peopleBiomarkers